Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Cot inhibitor-1

Cot inhibitor-1
Cot inhibitor-1 is a selective inhibitor of Cot protein kinase (also known as Tpl2 or MAP3K8) (IC50 at 28 nM). Cot inhibitor-1 inhibited TNF-alpha production in human whole blood with IC50 of 5.7 nM. Cot is involved in a variety of cellular signaling pathways, particularly those involved in inflammation and immune responses. Cot inactivate-1 inhibits Cot activity and may have potential therapeutic effects on rheumatoid arthritis, inflammatory bowel disease and some types of cancer.
Catalog No. T10865Cas No. 915365-57-0
Select Batch
Purity:99.19%
Contact us for more batch information

Resource Download

Cot inhibitor-1

Catalog No. T10865Cas No. 915365-57-0

Cot inhibitor-1 is a selective inhibitor of Cot protein kinase (also known as Tpl2 or MAP3K8) (IC50 at 28 nM). Cot inhibitor-1 inhibited TNF-alpha production in human whole blood with IC50 of 5.7 nM. Cot is involved in a variety of cellular signaling pathways, particularly those involved in inflammation and immune responses. Cot inactivate-1 inhibits Cot activity and may have potential therapeutic effects on rheumatoid arthritis, inflammatory bowel disease and some types of cancer.
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Pack SizePriceAvailabilityQuantity
1 mg$70In Stock
5 mg$163In Stock
10 mg$247In Stock
25 mg$446In Stock
50 mg$668In Stock
100 mg$985In Stock
1 mL x 10 mM (in DMSO)$196In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "Cot inhibitor-1"

Product Introduction

Bioactivity
Description
Cot inhibitor-1 is a selective inhibitor of Cot protein kinase (also known as Tpl2 or MAP3K8) (IC50 at 28 nM). Cot inhibitor-1 inhibited TNF-alpha production in human whole blood with IC50 of 5.7 nM. Cot is involved in a variety of cellular signaling pathways, particularly those involved in inflammation and immune responses. Cot inactivate-1 inhibits Cot activity and may have potential therapeutic effects on rheumatoid arthritis, inflammatory bowel disease and some types of cancer.
Targets&IC50
TNF-α:5.7 nM, Tpl2 kinase:28 nM
Chemical Properties
Molecular Weight553.46
FormulaC27H27Cl2FN8
Cas No.915365-57-0
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
H2O: 0.1 mg/mL (insoluble)
DMSO: 55 mg/mL (99.37 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.8068 mL9.0341 mL18.0682 mL90.3408 mL
5 mM0.3614 mL1.8068 mL3.6136 mL18.0682 mL
10 mM0.1807 mL0.9034 mL1.8068 mL9.0341 mL
20 mM0.0903 mL0.4517 mL0.9034 mL4.5170 mL
50 mM0.0361 mL0.1807 mL0.3614 mL1.8068 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Cot inhibitor-1 | purchase Cot inhibitor-1 | Cot inhibitor-1 cost | order Cot inhibitor-1 | Cot inhibitor-1 chemical structure | Cot inhibitor-1 formula | Cot inhibitor-1 molecular weight